TPTX News and Press, Turning Point Therapeutics Inc.

Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics, Inc. (NASDAQ:TPTX) (“Turning Point”) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR Act”), and the recei...

Turning Point Therapeutics press release ( NASDAQ: TPTX ): Q2 GAAP EPS of -$2.48 misses by $0.78 . Revenue of $0.12M (-97.7% Y/Y) misses by $2.15M . For further details see: Turning Point Therapeutics GAAP EPS of -$2.48 misses by $0.78, revenue of $0.12M ...

Positive feedback from pre-new drug application (NDA) meeting with U.S. Food and Drug Administration (FDA) focused on TRIDENT-1 registrational study of repotrectinib Initiated the Phase 1b/2 SHIELD-2 combination study of elzovantinib and aumolertinib in EGFR mutant MET...

SAN DIEGO, July 27, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for cancer treatment, today announced receipt of positive feedback from the U.S. Food and Drug Administ...

Update 11:20am: Adds German filing from late Thursday. Bristol Myers  Squibb ( NYSE: BMY ) is reportedly expected to make antitrust filings to U.S. and German authorities "imminently" for its planned $4.1 billion purchase of Turning Point Therapeutics ( NASDAQ:...

Bristol Myers  Squibb ( NYSE: BMY ) is reportedly expected to make antitrust filings to U.S. and German authorities "imminently" for its planned $4.1 billion purchase of Turning Point Therapeutics ( NASDAQ: TPTX ), according to a Dealreporter item. The ac...

The Health Care sector of the S&P 500 was in the red this month, with the Health Care Select Sector SPDR ETF ( XLV ) finishing 3% lower . The top five gainers in the health care sector (stocks with a market cap of over $2B) were: Turning Point Therapeutics...

The eleven sectors of the S&P 500 were 16.4% lower for Q2 2022, with SPDR S&P 500 Trust ETF closed more than 16% lower . The top five gainers in the health care sector (stocks with a market cap of over $2B) were: Turning Point Therapeutics ( TPTX ) +179.1...

NEW YORK, NY / ACCESSWIRE / June 29, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Steel Connect, Inc. (NASDAQ:STCN)'s ...

Bristol-Myers hits new highs, partly due to investors piling into drug stocks with the economy facing a potential recession. The biopharma faces the loss of exclusivity, or LOE, on its largest drug Revlimid while launching new drugs with the potential to replace the lost revenues of t...